Cerebellar and lobar blood flow in schizophrenia: A perfusion weighted imaging study

Psychiatry Research - Neuroimaging

Volumn 193, Issue 1, 2011, Pages 46-52

  Bellani, Marcella ^a   Peruzzo, Denis ^b   Isola, Miriam ^c   Rambaldelli, Gianluca ^a   Perlini, Cinzia ^a   Baiano, Monica ^d   Cerini, Roberto ^a   Andreone, Nicola ^a   Barillari, Marco ^a   Mucelli, Roberto Pozzi ^a   Balestrieri, Matteo ^c   Tansella, Michele ^a   Bertoldo, Alessandra ^b   Brambilla, Paolo ^c,e  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d Centre for Eating Disorders   (Italy)

^e SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Cerebellar blood flow; Cerebral blood flow; Gadolinium; MRI; Neuroimaging; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER;

ADULT; AGED; AREA UNDER CURVE; CEREBELLUM; CEREBROVASCULAR CIRCULATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PERFUSION IMAGING; PSYCHIATRIC STATUS RATING SCALES; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 79957591851     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.12.010     Document Type: Article

References (55)

1. Agarwal N., Port J.D., Bazzocchi M., Renshaw P.F. Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010, 255:23-41.
2. Amaddeo F., Burti L., Ruggeri M., Tansella M. Long-term monitoring and evaluation of a new system of community-based psychiatric care. Integrating research, teaching and practice at the University of Verona. Annali dell' Istituto Superiore di Sanità 2009, 45:43-53.
3. Andreasen N.C., O'Leary D.S.O., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve participants. Lancet 1997, 349:1730-1734.
4. Andreasen N.C., Paradiso S., O'Leary D.S. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?. Schizophrenia Bulletin 1998, 24:203-218.
5. Bachneff S.A. Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophrenia Bulletin 1996, 22:163-182.
6. Bellani M., Fagnani C., Brambilla P. Twin studies in psychotic disorders. Epidemiologia e Psichiatria Sociale 2009, 18:195-199.
7. Bellani M., Marzi C.A., Brambilla P. Interhemispheric communication in schizophrenia. Epidemiologia e Psichiatria Sociale 2009, 18:104-106.
8. Bellani M., Perlini C., Brambilla P. Language disturbances in schizophrenia. Epidemiologia e Psichiatria Sociale 2009, 18:314-317.
9. Benner T., Heiland S., Erb G., Forsting M., Sartor K. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magnetic Resonance Imaging 1997, 15:307-317.
10. Ben-Shachar D., Bonne O., Chisin R., Klein E., Lester H., Aharon-Peretz J., Yona I., Freedman N. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:807-813.
11. Brambilla P., Cerini R., Fabene P.F., Andreone N., Rambaldelli G., Farace P., Versace A., Perlini C., Polizza L., Gasparini A., Gatti R., Bellani M., Dusi N., Barbui C., Nosè M., Tournikioti K., Sbarbati A., Tansella M. Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study. Journal of Psychiatric Research 2007, 41:502-510.
12. Calamante F., Gadian D.G., Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potentials for clinical use. Stroke 2002, 33:1146-1151.
13. Chen J.J., Frayne R., Smith M.R. Reassessing the clinical efficacy of two MR quantitative DSC PWI CBF algorithms following cross-calibration with PET images. Physics in Medicine and Biology 2005, 50:1251-1263.
14. Cohen B.M., Yurgelun-Todd D., English C.D., Renshaw P.F. Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI. The American Journal of Psychiatry 1995, 152:1801-1803.
15. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Recalling word lists reveal "cognitive dysmetria" in schizophrenia: a positron emission tomography study. The American Journal of Psychiatry 1999, 156:386-392.
16. Davidson L.L., Heinrichs R.W. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research: Neuroimaging 2003, 122:69-87.
17. Davis C.E., Jeste D.V., Eyler L.T. Review of longitudinal functional neuroimaging studies of drug treatments in participants with schizophrenia. Schizophrenia Research 2005, 78:45-60.
18. Edelman R.R., Mattle H.P., Atkinson D.J., Hill T., Finn J.P., Mayman C., Ronthal M., Hoogewoud H.M., Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990, 176:211-220.
19. Ertugrul A., Volkan-Salanci B., Basar K., Karli Oguz K., Demir B., Ergun E.L., Senturk S., Erbas B., Cila A., Ulug B. The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response. Psychiatry Research: Neuroimaging 2009, 174:121-129.
20. Fujimoto T., Takeuch K., Matsumoto T., Kamimura K., Hamada R., Nakamura K., Kato N. Abnormal glucose metabolism in the anterior cingulate cortex in participants with schizophrenia. Psychiatry Research: Neuroimaging 2007, 154:49-58.
21. Gur R.E., Skolnick B.E., Gur R.C., Caroff S., Rieger W., Obrist W.D., Younkin D., Reivich M. Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Archives of General Psychiatry 1983, 40:1250-1254.
22. Gur R.E., Turetsky B.I., Loughead J., Snyder W., Kohle C., Elliott M., Ramapriyan Pratiwadi R., Ragland J.D., Bilker W.B., Siegel S.J., Kanes S.J., Arnold S.E., Gur R.C. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. The American Journal of Psychiatry 2007, 164:442-449.
23. Hanson D.R., Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular syntesis. Medical Genetics 2005, 6:7.
24. Kanahara N., Shimizu E., Sekine Y., Uchida Y., Shibuya T., Yamanaka H., Hashimoto T., Asaka T., Sasaki T., Miyatake R., Ohkami T., Fukami G., Fujisaki M., Watanabe H., Shirayama Y., Hayashi H., Hashimoto K., Asano M., Iyo M. Does hypofrontality expand to global brain area in progression of schizophrenia?: a cross-sectional study between first-episode and chronic schizophrenia. Progresses in Neuropsychopharmacology and Biological Psychiatry 2009, 33:410-415.
25. Kaneoke Y., Furuse M., Yoshida K., Saso K., Ichihara K., Motegi Y. Transfer index of MR relaxation enhancer: a quantitative evaluation of MR contrast enhancement. American Journal of Neuroradiology 1989, 10:329-333.
26. Kim J.J., Mohamed S., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. The American Journal of Psychiatry 2000, 157:542-548.
27. Lahti A.C., Holcomb H.H., Weiler M.A., Medoff D.R., Tamminga C.A. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry 2003, 53:601-608.
28. Laurens K.R., Kiehl K.A., Ngan E.T., Liddle P.F. Attention orienting dysfunction during salient novel stimulus processing in schizophrenia. Schizophrenia Research 2005, 15:159-171.
29. Lindenmayer J.P., Khan A., Iskander A., Abad M.T., Parker B. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. The Journal of Clinical Psychiatry 2007, 68:368-379.
30. Loeber R.T., Sherwood A.R., Renshaw P.F., Cohen B.M., Yurgelun-Todd D.A. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophrenia Research 1999, 37:81-89.
31. Loeber R.T., Gruber S.A., Cohen B.M., Renshaw P.F., Sherwood A.R., Yurgelun-Todd D.A. Cerebellar blood volume in bipolar participants correlates with medication. Biological Psychiatry 2002, 51:370-376.
32. Malaspina D., Harkavy-Friedman J., Corcoran C., Mujica-Parodi L., Printz D., Gorman J.M., Van Heertum R. Resting neural activity distinguishes subgroups of schizophrenia participants. Biological Psychiatry 2004, 56:931-937.
33. Miller D.D., Rezai K., Alliger R., Andreasen N.C. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biological Psychiatry 1997, 41:550-559.
34. Miller D.D., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological Psychiatry 2001, 49:704-715.
35. Molina V., Gispert J.D., Reig S., Sanz J., Pascau J., Santos A., Des Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology 2005, 178:17-26.
36. Novak B., Milcinski M., Grmek M., Kocmur M. Early effects of treatment on regional cerebral blood flow in first episode schizophrenia participants evaluated with 99Tc-ECD-SPECT. Neuroendocrinology Letters 2005, 26:685-689.
37. Ortuño F., Mobreno-Iñiguez M., Millán M., Soutullo C.A., Bonelli R.M. Cortical blood flow during rest and Wisconsin Card Sorting Test performance in schizophrenia. Wiener Medizinische Wochenschrift 2006, 156:179-184.
38. Østergaard L., Weisskoff R.M., Chesler D.A., Gyldensted C., Rosen B.R. High resolution measurements of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magnetic Resonance in Medicine 1996, 36:715-725.
39. Østergaard L., Sorensen A.G., Kwong K.K., Weisskoff R.M., Gyldensted C., Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magnetic Resonance in Medicine 1996, 36:726-736.
40. Porkka L., Neuder M., Hunter G., Weisskoff R.M., Belliveau J., Rosen B.R. Arterial input function measurement with MRI. Proceedings of ISMRM 10th Annual Meeting, San Francisco, California, USA 1991, 120.
41. Rosen B.R., Belliveau J.W., Aronen H.J., Kennedy D., Buchbinder B.R., Fishman A., Gruber M., Glas J., Weisskoff R.M., Cohen M.S., Hochberg F.H., Brady T.J. Susceptibility contrast imaging of cerebral blood volume: human experience. Magnetic Resonance in Medicine 1991, 22:293-299.
42. Sakaie K.E., Shin W., Curtin K.R., McCarthy R.M., Cashen T.A., Carroll T.J. Method for improving the accuracy of quantitative cerebral perfusion imaging. Journal of Magnetic Resonance Imaging 2005, 21:512-519.
43. Scheef L., Manka C., Daamen M., Kühn K.U., Maier W., Schild H.H., Jessen F. Resting-state perfusion in nonmedicated schizophrenic participants: a continuous arterial spin-labeling 3.0-T MR study. Radiology 2010, 256:253-260.
44. Schlösser R., Gesierich T., Kaufmann B., Vucurevic G., Hunsche S., Gawehn J., Stoeter P. Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modelling. Neuroimage 2003, 19:751-763.
45. Steinberg J.L., Devous M.D., Moeller F.G., Paulman R.G., Raese J.D., Gregory R.R. Cerebellar blood flow in schizophrenic participants and normal control subjects. Psychiatry Research: Neuroimaging 1995, 61:15-31.
46. Tansella M., Burti L. Integrating evaluative research and community-based mental health care in Verona, Italy. The British Journal of Psychiatry 2003, 183:167-169.
47. Schede di valutazione clinica in neuropsichiatria. SCAN 2.1 1996, Il Pensiero Scientifico Editore, Rome. M. Tansella, M. Nardini (Eds.).
48. Théberge J. Perfusion magnetic resonance imaging in psychiatry. Top Magnetic Resonance Imaging 2008, 19:111-130.
49. Ventura J., Nuechterlein K.H., Subotnik K.L., Gutkind D., Gilbert E.A. Symptom dimensions in recent-onset schizophrenia and mania: a principal component analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Research 2000, 97:129-135.
50. Wake R., Miyaoka T., Kawakami K., Tsuchie K., Inagaki T., Horiguchi J., Yamamoto Y., Hayashi T., Kitagaki H. Characteristic brain hypoperfusion by 99mTc-ECD single photon emission computed tomography (SPECT) in participants with the first-episode schizophrenia. European Psychiatry 2010, 25:361-365.
51. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., Shenton M.E., Green A.I., Nieto-Castanon A., LaViolette P., Wojcik J., Gabrieli J.D., Seidman L.J. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:1279-1284.
52. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., Jablenski A., Regier D., Sartorius N. SCAN. Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry 1990, 47:589-593.
53. Wu O., Østergaard L., Weisskoff R.M., Benner T., Rosen B.R., Sorensen A.G. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magnetic Resonance in Medicine 2003, 50:164-174.
54. Zierler K.L. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circulation Research 1962, 10:393-407.
55. Zierler K.L. Equations for measuring blood flow by external monitoring of radioisotopes. Circulation Research 1965, 16:309-321.